Literature DB >> 15960971

Identification of bronchioalveolar stem cells in normal lung and lung cancer.

Carla F Bender Kim1, Erica L Jackson, Amber E Woolfenden, Sharon Lawrence, Imran Babar, Sinae Vogel, Denise Crowley, Roderick T Bronson, Tyler Jacks.   

Abstract

Injury models have suggested that the lung contains anatomically and functionally distinct epithelial stem cell populations. We have isolated such a regional pulmonary stem cell population, termed bronchioalveolar stem cells (BASCs). Identified at the bronchioalveolar duct junction, BASCs were resistant to bronchiolar and alveolar damage and proliferated during epithelial cell renewal in vivo. BASCs exhibited self-renewal and were multipotent in clonal assays, highlighting their stem cell properties. Furthermore, BASCs expanded in response to oncogenic K-ras in culture and in precursors of lung tumors in vivo. These data support the hypothesis that BASCs are a stem cell population that maintains the bronchiolar Clara cells and alveolar cells of the distal lung and that their transformed counterparts give rise to adenocarcinoma. Although bronchiolar cells and alveolar cells are proposed to be the precursor cells of adenocarcinoma, this work points to BASCs as the putative cells of origin for this subtype of lung cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15960971     DOI: 10.1016/j.cell.2005.03.032

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  894 in total

Review 1.  Cancer stem cells: a stride towards cancer cure?

Authors:  Amitava Sengupta; Jose A Cancelas
Journal:  J Cell Physiol       Date:  2010-10       Impact factor: 6.384

2.  Isolation and characterization of stem-like cells from a human ovarian cancer cell line.

Authors:  Lijuan Wang; Roman Mezencev; Nathan J Bowen; Lilya V Matyunina; John F McDonald
Journal:  Mol Cell Biochem       Date:  2011-12-09       Impact factor: 3.396

3.  CARM1 is required for proper control of proliferation and differentiation of pulmonary epithelial cells.

Authors:  Karen B O'Brien; Meritxell Alberich-Jordà; Neelu Yadav; Olivier Kocher; Annalisa Diruscio; Alexander Ebralidze; Elena Levantini; Natasha J L Sng; Manoj Bhasin; Tyler Caron; Daehoon Kim; Ulrich Steidl; Gang Huang; Balázs Halmos; Scott J Rodig; Mark T Bedford; Daniel G Tenen; Susumu Kobayashi
Journal:  Development       Date:  2010-07       Impact factor: 6.868

Review 4.  The biology of head and neck cancer stem cells.

Authors:  Zhaocheng Zhang; Manoel Sant'Ana Filho; Jacques E Nör
Journal:  Oral Oncol       Date:  2011-11-08       Impact factor: 5.337

5.  Jaagsiekte sheep retrovirus infects multiple cell types in the ovine lung.

Authors:  Henny M Martineau; Chris Cousens; Stuart Imlach; Mark P Dagleish; David J Griffiths
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

6.  REV1 is implicated in the development of carcinogen-induced lung cancer.

Authors:  Chad A Dumstorf; Suparna Mukhopadhyay; Elangovan Krishnan; Bodduluri Haribabu; W Glenn McGregor
Journal:  Mol Cancer Res       Date:  2009-01-27       Impact factor: 5.852

7.  Achaete-scute complex homologue 1 regulates tumor-initiating capacity in human small cell lung cancer.

Authors:  Tianyun Jiang; Brendan J Collins; Ning Jin; David N Watkins; Malcolm V Brock; William Matsui; Barry D Nelkin; Douglas W Ball
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

8.  Multiple cells-of-origin of mutant K-Ras-induced mouse lung adenocarcinoma.

Authors:  Kate D Sutherland; Ji-Ying Song; Min Chul Kwon; Natalie Proost; John Zevenhoven; Anton Berns
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-28       Impact factor: 11.205

9.  Implication of in vivo circulating fibrocytes ablation in experimental pulmonary hypertension murine model.

Authors:  Vandana S Nikam; Sandeep Nikam; Akyl Sydykov; Katrin Ahlbrecht; Rory E Morty; Werner Seeger; Robert Voswinckel
Journal:  Br J Pharmacol       Date:  2020-04-12       Impact factor: 8.739

Review 10.  Chimeric antigen receptor T cell therapy in pancreatic cancer: from research to practice.

Authors:  Vishal Jindal; Ena Arora; Muhammad Masab; Sorab Gupta
Journal:  Med Oncol       Date:  2018-05-04       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.